The importance of antibody screens after transfusions

Transfusion

Volumn 56, Issue 11, 2016, Pages 2653-2654

  Sloan, Steven R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANEMIA; ANTIBODY DETECTION; ANTIBODY SCREENING; BLOOD BANK; BLOOD GROUP ABO SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD TRANSFUSION REACTION; COST BENEFIT ANALYSIS; EDITORIAL; ERYTHROCYTE TRANSFUSION; FATALITY; FETUS BLOOD; HEALTH CARE FACILITY; HOSPITAL SERVICE; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; MATERNAL EXPOSURE; OUTCOME ASSESSMENT; PATIENT RISK; PHLEBOTOMY; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; THALASSEMIA; TRANSFUSION MEDICINE; TREATMENT FAILURE; BLOOD TRANSFUSION; THROMBOCYTE TRANSFUSION;

BLOOD TRANSFUSION; HUMANS; PLATELET TRANSFUSION;

EID: 84994378339     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13818     Document Type: Editorial

References (10)

1. Stack G, Tormey C. Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence. Transfusion 2016;56:2662-67.
2. Transfusion/donation fatalities [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services; 2016 [cited 2016 Aug 29]. Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/default.htm. Accessed 2016 Aug 19.
3. Annual SHOT reports 2015 [Internet]. Manchester: The SHOT Office; 2016 [cited 2016 Aug 29]. Available from: http://www.shotuk.org/shot-reports/. Accessed 2016 Aug 29.
4. Ness PM, Shirey RS, Thoman SK, et al. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990;30:688-93.
5. Storry JR. Other blood group systems and antigens. In: Fung MK, Grossman BJ, Hilllyer CD, Westhoff CM, editors. Technical manual. Bethesda (MD): AABB; 2014. p. 337-66.
6. Delaney M, Dinwiddie S, Nester TN, et al. The immunohematologic and patient safety benefits of a centralized transfusion database. Transfusion 2013;53:771-6.
7. Harm SK, Yazer MH, Monis GF, et al. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol 2014;141:256-61.
8. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127-31.
9. Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009;49:505-12.
10. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546-53.